---
figid: PMC9922847__fimmu-14-1099071-g005
pmcid: PMC9922847
image_filename: fimmu-14-1099071-g005.jpg
figure_link: /pmc/articles/PMC9922847/figure/f5/
number: FigureÂ 5
figure_title: ''
caption: Clinical response to anti-tumor treatment and immune checkpoint-related gene
  expression in high and low-risk groups. (A) The prediction of chemotherapy and molecular
  medicines based on the risk groups (B) The difference in immune checkpoint expression
  in high-risk and low-risk groups. (C) Correlations between risk score and immune
  infiltrating cells. (D) Correlations between risk score and immunotherapy-predicted
  pathway enrichment scores. *p < 0.05, **p < 0.01, ***p < 0.001.
article_title: Identification of a novel immune-related gene signature for prognosis
  and the tumor microenvironment in patients with uveal melanoma combining single-cell
  and bulk sequencing data.
citation: Wanpeng Wang, et al. Front Immunol. 2023;14:1099071.
year: '2023'

doi: 10.3389/fimmu.2023.1099071
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.

keywords:
- uveal melanoma
- immune-related gene
- prognostic signature
- immune checkpoint
- tumor microenvironment

---
